Copyright ©ERS Journals Ltd 2004 Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome1 Dept of Medicine, 2 Intensive Care Unit, and 3 Dept of Radiology, United Christian Hospital, and 4 Dept of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China CORRESPONDENCE: C.M. Chu, Division of Respiratory Medicine, Dept of Medicine, United Christian Hospital, Hong Kong SAR, China. Fax: 85 223472325 E-mail: nncmchu@netvigator.com Keywords: Complication, coronavirus, pneumomediastinum, pneumothorax, severe acute respiratory syndrome
Received: August 22, 2003
Spontaneous pneumomediastinum (SP) unrelated to assisted ventilation is a newly recognised complication of severe acute respiratory syndrome (SARS). The objective of the present study was to examine the incidence, risk factors and the outcomes of SP in a cohort of SARS victims from a community outbreak.
Data were retrieved from a prospectively collected database of virologically confirmed SARS patients. One hundred and twelve cases were analysable, with 13 patients developing SP (11.6%) at a mean±sd of 19.6±4.6 days from symptom onset.
Peak lactate dehydrogenase level was associated with the development of SP. SP was associated with increased intubation and a trend towards death. Drainage was required in five cases. For patients who survived, the SP and/or the associated pneumothoraces took a median of 28 days (interquartile range: 1545 days) to resolve completely.
In conclusion, spontaneous pneumomediastinum appeared to be a frequent complication of severe acute respiratory syndrome. Further research is needed to investigate its pathogenesis.
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||